InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
2
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+12.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Broadfoot Jill Marie, Chief Financial Officer. Insider active across 4 companies, notably Acelrx Pharmaceuticals INC. Cumulatively, 12 disclosures have been logged. Split: 2 buys · 0 sell. Total volume traded: €20k. Activity tracked since 20 November 2021. The latest transaction was disclosed on 23 October 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Broadfoot Jill Marie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
5,100 sharesCommon StockSEC:0001305178-26-000002:0
3,750 sharesCommon StockSEC:0001193125-26-038002:0
4,267 shares0Common StockSEC:0001305178-25-000004:0
3,750 sharesCommon StockSEC:0000950170-25-013884:0
2,174 shares0Common StockSEC:0001415889-24-018073:0
5,000 shares@ US$1.7942.1% of flowCommon StockSEC:0000950170-24-067668:0
Canonical exit: 29 Aug 2024 (T+90)
3,750 sharesCommon stockSEC:0001209191-24-002947:0
581 shares0Common StockSEC:0001209191-23-058479:0
3,750 sharesCommon stockSEC:0001209191-23-007364:0
15,500 shares0Common StockSEC:0001209191-22-042311:0
1,923 shares@ US$6.7557.9% of flowCommon stockSEC:0001209191-22-003419:0
Canonical exit: 13 Apr 2022 (T+90)
15,000 shares0Common StockSEC:0001209191-21-066559:0
12 of 12 declarations
About Broadfoot Jill Marie
Broadfoot Jill Marie is Directeur Financier and holds roles at aTYR PHARMA INC, TALPHERA, INC., and Acelrx Pharmaceuticals INC. She has 12 filings in total, and across the 12 sampled recent filings between 2021-11-23 and 2026-06-24, buys amount to EUR 19605, with no sells, and the most frequent transaction nature is Attribution.
